-+ 0.00%
-+ 0.00%
-+ 0.00%

NATERA INC: FETAL FOCUS ACHIEVED 96% SENSITIVITY AND 98% SPECIFICITY IN VALIDATION FROM PROSPECTIVE BLINDED EXPAND CLINICAL TRIAL

Reuters·01/05/2026 12:02:54

Please log in to view news